SignalFDA/Bio

Beam drops after updating Phase 1/2 trial data for gene-editing drug

Phase 1/2 trial data update triggered biotech selloff.

What changed

Phase 1/2 trial data update triggered biotech selloff.

Why it matters

Phase 1/2 trial data update triggered biotech selloff. — impact context not separately stored; see What changed.

Sources